1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 11-20 of 20 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2008Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trialDavis, S.; Donnan, G.; Parsons, M.; Levi, C.; Butcher, K.; Peeters, A.; Barber, P.; Bladin, C.; De Silva, D.; Byrnes, G.; Chalk, J.; Fink, J.; Kimber, T.; Schultz, D.; Hand, P.; Frayne, J.; Hankey, G.; Muir, K.; Gerraty, R.; Tress, B.; et al.
2009Anorectal function after three- versus two-dimensional radiation therapy for carcinoma of the prostateYeoh, E.; Holloway, R.; Fraser, R.; Botten, R.; Di Matteo, A.; Moore, J.; Schoeman, M.; Bartholomeusz, F.
2004A prospective study of the use of cryosurgery for the treatment of actinic keratosesThai, K.; Fergin, P.; Freeman, M.; Vinciullo, C.; Francis, D.; Spelman, L.; Murrell, D.; Anderson, C.; Weightman, W.; Reid, C.; Watson, A.; Foley, P.
2006The Australian Mohs database: Short-term recipient-site complications in full-thickness skin graftsLeibovitch, I.; Huilgol, S.; Richards, S.; Paver, R.; Selva-Nayagam, D.
2009Dasatinib treatment of chronic-phase chronic myeloid leukemia: analysis of responses according to preexisting BCR-ABL mutationsMuller, M.; Cortes, J.; Kim, D.; Druker, B.; Erben, P.; Pasquini, R.; Branford, S.; Hughes, T.; Radich, J.; Ploughman, L.; Mukhopadhyay, J.; Hochhaus, A.
2007Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: A planned safety analysis in 1 864 patientsSchmoll, H.; Cartwright, T.; Tabernero, J.; Nowacki, M.; Figer, A.; Maroun, J.; Price, T.; Lim, R.; Van Custem, E.; Park, Y.; McKendrick, J.; Topham, C.; Soler-Gonzalez, G.; de Braud, F.; Hill, M.; Sirzen, F.; Haller, D.
2009Dasatinib in the Treatment of Chronic Myeloid Leukemia in Accelerated Phase After Imatinib Failure: The START A TrialApperley, J.; Cortes, J.; Kim, D.; Roy, L.; Roboz, G.; Rosti, G.; Bullorsky, E.; Abruzzese, E.; Hochhaus, A.; Heim, D.; De Souza, C.; Larson, R.; Lipton, J.; Khoury, J.; Kim, H.; Sillaber, C.; Hughes, T.; Erben, P.; Tornout, J.; Stone, R.
2004Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancerSuwiwat, S.; Ricciardelli, C.; Tammi, R.; Tammi, M.; Auvinen, P.; Kosma, V.; LeBaron, R.; Raymond, W.; Tilley, W.; Horsfall, D.
2008Analgesic nephropathy and renal replacement therapy in Australia: Trends, Comorbidities and outcomesChang, S.; Mathew, T.; McDonald, S.
2006Periocular and orbital amyloidosis - Clinical characteristics, management, and outcomeLeibovitch, I.; Selva-Nayagam, D.; Goldberg, R.; Sullivan, T.; Saeed, P.; Davis, G.; McCann, J.; McNab, A.; Rootman, J.

Discover